Ascentage Pharma Group International

NASDAQ:AAPG

Biotechnology

Healthcare
$12.44 +1.78%

+$0.31 today

Market cap
$1.16B
Beta
0.65
P/E (TTM)
-8.9
EPS (TTM)
-$13.29
52W Low $16.92High $48.45

Volume 0.00M

Average 0.01M

Income Statement

Follow revenue through to earnings.

Revenue

$558.48M

FY 2025 · Annual

-43.1% YoY

Operating Income

-$1.18B

FY 2025 · Annual

Net Income

-$1.21B

FY 2025 · Annual

Income Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue27.91M209.71M221.98M980.65M558.48M
Cost of Revenue3.33M22M30.54M29.09M131.73M
Gross Profit24.58M187.71M191.44M951.57M426.75M
Gross Margin88.1%89.5%86.2%97.0%76.4%
Research & Development766.49M743.1M706.97M947.25M1.08B
Selling, General & Admin191.26M328.02M376.46M383.12M522.67M
Operating Expenses957.75M1.04B1.06B1.32B1.61B
Depreciation & Amortization17.18M47.42M93.2M93.17M84.12M
EBITDA(798.34M)(786.97M)(743.61M)(237.63M)(1.1B)
EBITDA Margin-2860.4%-375.3%-335.0%-24.2%-196.1%
Operating Income(869.84M)(849.81M)(872.64M)(369.73M)(1.18B)
Operating Margin-3116.6%-405.2%-393.1%-37.7%-211.1%
Interest Income7.11M9.73M32.41M37.84M79.89M
Interest Expense16.73M52.79M96.06M64.46M52.6M
Other Income / Expenses37.59M(37.36M)(60.23M)(25.53M)(23.21M)
Income Before Tax(832.25M)(887.17M)(932.86M)(395.26M)(1.2B)
Pre-Tax Margin-2981.9%-423.0%-420.2%-40.3%-215.3%
Income Tax Expense(49.83M)(4.25M)(7.15M)10.43M6.75M
Net Income(782.42M)(882.92M)(925.64M)(405.43M)(1.21B)
Net Margin-2803.4%-421.0%-417.0%-41.3%-216.5%
EPS (Basic)(49.12)(53.60)(52.48)(5.36)(13.56)
EPS (Diluted)(49.12)(53.60)(52.48)(5.36)(13.56)
Weighted Avg Shares15.91M16.48M17.64M75.52M89.03M
Weighted Avg Shares (Diluted)15.91M16.48M17.64M75.52M89.03M

AAPG Earnings Waterfall · TTM

NASDAQ:AAPG · Revenue to Net Income

Key Ratios

EPS$-18.92
Gross Margin89.9%
Net Margin-196.7%
P/E Ratio-1.7
P/S Ratio57.1

Analysis

$1.5B of revenue converted into -$1.6B of net income for the selected period. Gross margin is 89.9% and net margin is -196.7%, showing how much revenue survives after costs and taxes. EPS is $-18.92, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 5, 2026
6-K6-K filingOct 28, 2026
6-K6-K filingOct 22, 2026
6-K6-K filingOct 21, 2026
6-K6-K filingOct 15, 2026

How much revenue does AAPG generate?

Ascentage Pharma Group International (AAPG) reported $558.48M of revenue in fiscal 2025.

Is AAPG profitable?

Ascentage Pharma Group International (AAPG) reported -$1.21B of net income, with a net margin of -216.5%.